• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconFDA

FDA

Page 14 of 36
Pfizer submits request to authorize COVID vaccine for kids to FDA
HealthPfizer submits request to authorize COVID vaccine for kids to FDA
By Robert Langreth, Catherine Larkin and BloombergOctober 7, 2021
Merck's antiviral pill for COVID-19
HealthEverything to know about Merck’s COVID antiviral pill
By Emily MullinOctober 5, 2021
Pfizer vaccine
HealthWho can get a booster shot?
By Brett HaenselSeptember 29, 2021
Scott Gottlieb
HealthEx-FDA chief Scott Gottlieb on COVID vaccine rollout failures, mix and match vaccines, and end of Delta wave
By Brett HaenselSeptember 28, 2021
Pfizer submits COVID vaccine data from kids 5 to 11 to FDA
HealthPfizer submits COVID vaccine data from kids 5 to 11 to FDA
By The Associated PressSeptember 28, 2021
Days after the FDA rejected COVID booster shots for people 16 and up, a CDC panel will decide who gets an extra dose
HealthDays after the FDA rejected COVID booster shots for people 16 and up, a CDC panel will decide who gets an extra dose
By Lauran Neergaard, Mike Stobbe and The Associated PressSeptember 22, 2021
J&J says COVID booster dose provides 100% protection against severe disease
HealthJ&J says COVID booster dose provides 100% protection against severe disease
By Robert Langreth and BloombergSeptember 21, 2021
Medical professional with Covid-19 vaccine
HealthWhen to expect COVID vaccine booster shots
By Brett HaenselSeptember 20, 2021
Pfizer vaccine
HealthWhat comes next for COVID booster shots after the FDA panel hedges on Pfizer
By Sy MukherjeeSeptember 17, 2021
Pfizer headquarters
HealthFDA panel recommends COVID-19 boosters only for those 65 and older or at high risk
By Robert Langreth, Fiona Rutherford and BloombergSeptember 17, 2021
The fate of Biden’s ambitious COVID booster plan lies in the hands of FDA advisors
HealthThe fate of Biden’s ambitious COVID booster plan lies in the hands of FDA advisors
By Matthew Perrone, Lauran Neergaard and The Associated PressSeptember 17, 2021
Gavin Newsom recall COVID politics
NewslettersThe failed bid to topple Gavin Newsom and the politics of public health
By Sy MukherjeeSeptember 16, 2021
FDA strikes neutral tone ahead of Friday’s COVID vaccine booster meeting
HealthFDA strikes neutral tone ahead of Friday’s COVID vaccine booster meeting
By Lauran Neergaard, Matthew Perrone and The Associated PressSeptember 15, 2021
The FDA is rapidly reviewing COVID vaccines for children under 12
HealthThe FDA is rapidly reviewing COVID vaccines for children under 12
By Fiona Rutherford and BloombergSeptember 10, 2021
FDA delays decision on whether Juul can remain on the market
HealthFDA delays decision on whether Juul can remain on the market
By Matthew Perrone and The Associated PressSeptember 9, 2021
1...
  • 12
  • 13
  • 14
  • 15
  • 16
...36
Most Popular
Asia
Pentagon accuses Alibaba, Baidu and BYD, three of China's biggest companies, of supporting the Chinese militaryplaceholder alt text
By Kate O'Keeffe and BloombergJune 8, 2026
Economy
'We are rapidly running out of time': Watchdog sounds Social Security alarm after 22% cut confirmed for 2032placeholder alt text
By Nick LichtenbergJune 9, 2026
Success
Costco CEO Ron Vachris rose from forklift driver to the C-suite without a college degree: ‘Don’t chase a title’ is the career advice that got him thereplaceholder alt text
By Preston ForeJune 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.